Skip to main content
. 2011 Dec 12;6(12):e28887. doi: 10.1371/journal.pone.0028887

Figure 2. Effects of the ABAD inhibitor AG18051 on cell viability and estradiol levels.

Figure 2

(A) LDH assay of SH-SY5Y human neuroblastoma cells incubated with increasing concentrations of AG18051 (normalized to 1 for control) shows that the ABAD inhibitor is not toxic at concentrations of 0.1 µM and below. (B) Treatment of SH-SY5Y cells with increasing concentrations of AG18051 causes reduced levels of estradiol. *, P<0.05.